Shopping Cart
- Remove All
- Your shopping cart is currently empty
MT1, a bivalent chemical probe targeting BET bromodomains, demonstrates an IC50 value of 0.789 nM for BRD4(1).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | 827 € | Backorder |
Description | MT1, a bivalent chemical probe targeting BET bromodomains, demonstrates an IC50 value of 0.789 nM for BRD4(1). |
In vitro | MT1 (100 nM, 24 h) prominently induces apoptosis in MV4;11 cells via caspase-3 and PARP pathways, evidenced by substantial caspase-3 and PARP cleavage in Western Blot Analysis [1]. |
In vivo | MT1, administered intraperitoneally at doses of 44.2 and 22.1 μmol/kg daily for 14 days, significantly delayed the progression of leukemia in mice (Mus musculus) in comparison to the control, JQ1. Additionally, MT1 demonstrated a terminal half-life (t 1/2) of 2.70 hours in mice. In the context of leukemia xenograft models, this regimen markedly reduced the leukemic burden over the study period when compared to either the vehicle or JQ1. |
Molecular Weight | 1134.2 |
Formula | C54H66Cl2N10O9S2 |
Cas No. | 2060573-82-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.